Muscle Growth & Performance
GHRH analogs, ghrelin mimetics, and IGF-1 pathway compounds studied in performance and recomposition research.
21 peptides in this category
BPC-157 + TB-500
Combined research protocol pairing localized tissue repair with systemic recovery.
CJC-1295
Modified GHRH analog that amplifies and extends growth hormone pulses.
CJC-1295 No DAC + Ipamorelin
Combined GHRH + GHRP research stack designed to amplify natural GH pulses.
Ipamorelin
Selective GHRP that stimulates clean growth hormone pulses with minimal side effects.
TB-500
Systemic recovery research peptide derived from thymosin beta-4.
CJC-1295 DAC
Albumin-binding GHRH analog studied for sustained GH and IGF-1 elevation.
EPO
Recombinant hormone that drives red blood cell production.
HGH 191AA
Recombinant 191-amino-acid human growth hormone — the reference standard.
HGH Fragment 176-191
C-terminal fragment of human growth hormone studied for lipolytic effects without affecting glucose or IGF-1.
ACE-031
Soluble activin receptor researched as a myostatin and activin trap to promote lean mass.
Follistatin
Glycoprotein researched for myostatin inhibition and muscle hypertrophy.
GHRP-2
Classic GHRP studied for reliable, moderate growth hormone release.
GHRP-6
Early-generation ghrelin mimetic researched for GH release and appetite stimulation.
Hexarelin
Most potent of the classic GHRPs with strong cardioprotection research signals.
IGF-1 LR3
Long-acting IGF-1 variant studied for anabolic and recovery effects.
MGF
Splice variant of IGF-1 researched for local muscle repair and satellite cell activation.
PEG-MGF
PEGylated, long-acting form of MGF researched for systemic muscle repair.
Sermorelin
First 29 amino acids of GHRH studied for stimulating the body's own GH production.
Tesamorelin
Stabilized GHRH analog studied for visceral adipose reduction.
AICAR
AMPK activator researched as an exercise mimetic.
TB-500 Fragment (17-23)
Short actin-binding fragment of thymosin beta-4 studied as a TB-500 alternative.

